Ajuste direto para aquisição de L1066 - LENVATINIB [10 MG; CÁP/ COMP] e L1067 - LENVATINIB [4 MG; CÁP/ COMP] para suprir necessidades na área da saúde.

ID 13390998 · Portal BASE
Price
Base Price
€129,769 .00
Effective Price
€7,078 .00 -94.5%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Penafiel
Bidder Count
—
Winner
EISAI FARMACEUTICA UNIPESSOAL LDA.
NIF 507847660
Company
Dates
Publication
13 Feb 2026
Celebration
16 Jan 2026
Contracting Entity
Centro Hospitalar do Tâmega e Sousa, EPE
NIF 508318262
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
13 Feb 2026
Signing Date
16 Jan 2026
Days Late
28
Rule
A2/A3 late publication: 28 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
129769.0
Total effective price
7078.0
Ratio
0.0545
Direction
reduction
Rule
A9 price reduction: ratio 0.0545 outside [0.5, 1.5]
Detected 2026-03-06